InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,022.21
(
-0.58%
)
US TECH 100
17,104.80
(
0.42%
)
Dow Jones
37,753.31
(
0.00%
)
Brent Oil
86.40
(
-0.68%
)
Bitcoin
62,625.68
(
2.19%
)
Post# of 8484
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

maumar

Send PM Follow Ignore
Followers 5
Posts 856
Boards Moderated 0
Alias Born 09/28/2012

maumar

Member Level

Re: maumar post# 5350

Tuesday, 10/31/2017 11:26:58 AM

Tuesday, October 31, 2017 11:26:58 AM

Post# of 8484
"The initial Phase 3 study is in amyloidosis patients, with additional Phase 3 studies in multiple myeloma and smoldering myeloma patients planned for near-term initiation."

It's not spelled out but I wonder if Halo will get a $15M milestone payment for each Phase 3 trial.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent HALO News
More HALO News
InvestorsHub NewsWire

ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM

Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM

Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM

Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM

Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM

Branded Legacy, Inc. Reports Significant Net Income of Over $3.8 Million • BLEG • Apr 16, 2024 8:30 AM

Start posting your company's news
Only $200 per official company press release!